Singapore -- Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute M

read more>>

Counterfeiting of drugs is a huge industry with an annual turnover of more than SEK 500 billionIn Africa the situation is extremely serious. Half of the malaria medication sold there could be ineffective or even harmful. Researchers from Lund and the UK have now developed a technique that could re

read more>>

The Ministry of Public Health and Sanitation has received a major boost up in its efforts to fight malaria in the country after the Global Fund announced Ksh 3.06 billion grant to the Kenyan governmentSpeaking during the launch of Affordable Medicines Facility for Malaria (AMFm) in Nairobi Thursda

read more>>

An experimental malaria drug developed by Ranbaxy Laboratories Ltd. was effective and safe in a mid-stage clinical trial, according to a study that suggests the treatment may offer an alternative to current medicinesAmong 230 people with the deadliest form of malaria in Thailand, India and Tanzani

read more>>

In research published this week in PLoS Medicine Stephen Lim and colleagues (University of Washington) systematically estimate the changes in distribution of insecticide-treated bed nets (ITNs) across Africa between 2000 and 2008, and find that several countries have managed to scale up their ITN

read more>>

Global initiatives to control specific diseases, such as polio or worm diseases, in low income countries not only do goodSometimes they pull people and resources away from basic health care. Then the remedy may be worse than the disease. In an article in the open-access journal PLoS Neglected Trop

read more>>

STANFORD, Calif. -- Gene variants associated with an increased risk for type-1 diabetes and rheumatoid arthritis may confer previously unknown benefits to their human carriers, say researchers at the Stanford University School of MedicineAs a result, the human race may have been evolving in the re

read more>>

Geneva -- With an agreement signed today, MMV (Medicines for Malaria Venture)became the first product development partnership (PDP) to contribute intellectual property to the Pool for Open Innovation Against Neglected Tropical DiseasesThe Pool was established in February 2009 by GSK (GlaxoSmithKli

read more>>

As part of the £1.5 million project, researchers are now testing the drug to determine how the treatment could progress to clinical trialsThe drug is made from simple organic molecules and will be cheaper to mass produce compared to existing therapiesMalaria is the world's most deadly paras

read more>>

During the recent African Union summit, the African Leaders Malaria Alliance (ALMA) gathered to discuss how to combat the threat of malaria in the continentInspired by this meeting, Madiké Seye, Vice-President for Africa – GlaxoSmithKline wrote a guest article on the Independent&rsqu

read more>>